| Schedule Share Based Compensation Expenses |
Stock-based compensation expense is principally related to awards issued pursuant to the Legacy Innovid Stock Option Plan (“Legacy Plan”) and 2021 Innovid Corp. Incentive Plan (“2021 Plan”) and is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
2022 |
|
2021 |
|
(Unaudited) |
|
(Unaudited) |
Cost of goods sold |
$ |
105 |
|
|
$ |
5 |
|
Research and development |
479 |
|
|
51 |
|
Sales and marketing |
580 |
|
|
87 |
|
General and administrative |
399 |
|
|
118 |
|
Total |
$ |
1,563 |
|
|
$ |
261 |
|
|
| Share-based Payment Arrangement, Option, Activity |
A summary of the employees’ stock option activity under the Legacy Plan for the three months ended March 31, 2022 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, 2022 |
|
|
|
(Unaudited) |
|
|
|
Amount
of
options
|
|
Weighted
average
exercise
price
|
|
Weighted
average
remaining contractual term
(in years)
|
|
Aggregate intrinsic value (in thousands) |
Outstanding at beginning of period
|
11,122,648
|
|
|
$ |
0.82
|
|
|
6.87 |
|
$ |
64,818
|
|
| Transfer between employee and consultant |
40,118 |
|
|
0.64 |
|
|
|
|
|
| Granted in acquisition |
949,893 |
|
|
0.31 |
|
|
|
|
|
| Forfeited |
(16,053) |
|
|
1.81 |
|
|
|
|
|
| Expired |
(7,830) |
|
|
0.61 |
|
|
|
|
|
| Exercised |
(1,452,971) |
|
|
0.30 |
|
|
|
|
|
Outstanding at end of period
|
10,635,805
|
|
|
$ |
0.84
|
|
|
7.70 |
|
$ |
55,276
|
|
Exercisable options at end of period
|
7,122,369
|
|
|
$ |
0.56
|
|
|
7.25 |
|
$ |
39,000
|
|
A summary of the consultants’ stock option activity under the Legacy Plan for the three months ended March 31, 2022 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, 2022 |
|
|
|
(Unaudited) |
|
|
|
Amount
of
options
|
|
Weighted
average
exercise
price
|
|
Weighted
average
remaining contractual term
(in years)
|
|
Aggregate intrinsic value (in thousands) |
Outstanding at beginning of period
|
179,627
|
|
|
$ |
0.31
|
|
|
2.34 |
|
$ |
1,139
|
|
| Transfer between employee and consultant |
(40,118) |
|
|
0.64 |
|
|
|
|
|
| Exercised |
(69,298) |
|
|
0.30 |
|
|
|
|
|
Outstanding at end of period
|
70,211
|
|
|
$ |
0.49
|
|
|
5.01 |
|
$ |
390
|
|
Exercisable options at end of period
|
60,516
|
|
|
$ |
0.45
|
|
|
4.49 |
|
$ |
338
|
|
|